Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders-Reference-Cited by-同舟云学术

Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders

Published:2018-10-15 Issue:2 Volume:46 Page:376-384
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Gabilondo Iñigo,Llorens Verónica,Rodriguez Trinidad,Fernández Manuel,Concha Tomas Pérez,Acera Marian,Tijero Beatriz,Murueta-Goyena Ane,del Pino Rocío,Cortés Jesús,Gómez-Esteban Juan Carlos

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4183-0/fulltext.html

Reference31 articles.

1. Goldstein DS. Sympathetic neuroimaging. Handb Clin Neurol. 2013;117:365–70. https://doi.org/10.1016/B978-0-444-53491-0.00029-8 .

2. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;67:189–94.

3. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–8. https://doi.org/10.1212/01.wnl.0000249313.25627.2e .

4. Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D, et al. SCOPA-AUT scale in different parkinsonisms and its correlation with (123)I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord. 2012;18:45–8. https://doi.org/10.1016/j.parkreldis.2011.08.018 .

5. Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med. 2004;18:453–61.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body-first and Brain-first Parkinson's Disease Subtypes Exhibit Distinctive Gut Microbial Dysbiotic Patterns;2024-01-11

2. Reduced cardiac 123I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder;Brain Communications;2024

3. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases;Neurología (English Edition);2023-11

4. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review;Brain Sciences;2023-10-18

5. Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder;Journal of Neurology;2023-05-26